Back
BridgeBio Pharma, Inc. 10K Form
Sell
40
BBIO
BridgeBio Pharma, Inc.
Last Price:
$70.14
Seasonality Move:
3.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBIO News And Ratings
See the #1 stock for the next 7 days that we like better than BBIO
BBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $502.1M |
|---|---|
| Cash Flow: | $-56.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-10.71 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -3.78420 |
|---|---|
| Net Income (TTM): | $-732.9M |
| Gross Margin: | $478.4M |
| Return on Equity: | 0% |
| Return on Assets: | -76.1% |
BridgeBio Pharma, Inc. Earnings Forecast
Key BridgeBio Pharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for BBIO is 95.28%.
-
The Selling, General & Administrative Expenses for BBIO have been equal to 105.81% of Gross Profit Margin.
-
The Research & Development expenses have been 90.02% of Revenue.
-
The Net Earning history of BBIO is -145.98% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 2 years.
BridgeBio Pharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBIO |
| CUSIP: | 10806X |
| Website: | bridgebio.com |
Debt
| Debt-to-Equity Ratio: | -1.31 |
|---|---|
| Current Ratio: | 2.77 |
| Quick Ratio: | 2.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 35060 |
BBIO Technical Analysis vs Fundamental Analysis
Sell
40
BridgeBio Pharma, Inc. (BBIO)
is a Sell
Is BridgeBio Pharma, Inc. a Buy or a Sell?
-
BridgeBio Pharma, Inc. stock is rated a SellThe current BridgeBio Pharma, Inc. [BBIO] share price is $70.12. The Score for BBIO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.